Cover Image
市場調查報告書

Uni-Bio Science Group Ltd. 的產品平台分析

Uni-Bio Science Group Ltd. - Product Pipeline Review - 2015

出版商 Global Markets Direct 商品編碼 256060
出版日期 內容資訊 英文 25 Pages
訂單完成後即時交付
價格
Back to Top
Uni-Bio Science Group Ltd. 的產品平台分析 Uni-Bio Science Group Ltd. - Product Pipeline Review - 2015
出版日期: 2015年09月30日 內容資訊: 英文 25 Pages
簡介

Uni-Bio Science Group Ltd. 是總公司設立在香港的製藥企業,進行以重組DNA技術平台為基礎的下一代醫藥品的開發及銷售。開發平台有第二型糖尿病治療藥,化療引起的血小板減少性疾病的治療藥等。

本報告提供Uni-Bio Science Group Ltd. 的治療藥開發平台的現狀及各開發階段比較分析、各藥物標靶、作用機制、給藥途徑、分子類型的治療藥的評估、最新的企業新聞和發表、後期階段及中止的計劃相關資訊等。

目錄

Uni-Bio Science Group Ltd. 基本資料

  • Uni-Bio Science Group Ltd. 概要
  • 主要資訊
  • 企業資料

Uni-Bio Science Group Ltd. :R&D概要

  • 主要的治療範圍

Uni-Bio Science Group Ltd. :開發平台的檢討

  • 各開發階段的開發中產品
  • 單劑產品

Uni-Bio Science Group Ltd. :開發中產品概況

  • 後期階段產品開發中產品
    • 第三階段的產品/聯合治療模式
  • 在臨床階段的開發中產品
    • 第一階段的產品/聯合治療模式
  • 初期階段的開發中產品
    • 前臨床階段的產品/聯合治療模式

Uni-Bio Science Group Ltd. :藥物簡介

  • rExendin-4
  • teriparatide
  • rhEPO-Fc
  • cTP-5
  • LExendin-4
  • LFA3-Fc

Uni-Bio Science Group Ltd. :開發平台分析

  • 各標靶
  • 各給藥途徑
  • 各分子類型
  • 各作用機制

Uni-Bio Science Group Ltd. :開發中止的開發中產品

  • 開發中止的開發中產品簡介
    • UNI-rhIL11

Uni-Bio Science Group Ltd. :總公司和子公司的所在地

  • 總公司

附錄

圖表一覽

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

目錄
Product Code: GMDHC07636CDB

Summary

Global Markets Direct's, 'Uni-Bio Science Group Ltd. - Product Pipeline Review - 2015', provides an overview of the Uni-Bio Science Group Ltd.'s pharmaceutical research and development focus.

This report provides comprehensive information on the current therapeutic developmental pipeline of Uni-Bio Science Group Ltd.'s, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. It also reviews latest updates, and featured news and press releases, along with special features on late-stage and discontinued projects.

Global Markets Direct's report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Direct's proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct's team. Drug profiles/records featured in the report undergoes periodic updation following a stringent set of processes that ensures that all the profiles are updated with the latest set of information. Additionally, processes including live news & deals tracking, browser based alert-box and clinical trials registries tracking ensure that the most recent developments are captured on a real time basis.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products.

Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

  • The report provides brief overview of Uni-Bio Science Group Ltd. including business description, key information and facts, and its locations and subsidiaries
  • The report reviews current pipeline of Uni-Bio Science Group Ltd.'s human therapeutic division and enlists all their major and minor projects
  • The report features product description and descriptive mechanism of action for key pipeline products along with the product's developmental history and major milestones
  • Special feature on out-licensed and partnered product portfolio
  • The report summarizes all the dormant and discontinued pipeline projects
  • Latest company statement
  • Latest news and deals relating to the Uni-Bio Science Group Ltd.'s pipeline products

Reasons to buy

  • Evaluate Uni-Bio Science Group Ltd.'s strategic position with total access to detailed information on its product pipeline
  • Assess the growth potential of Uni-Bio Science Group Ltd. in its therapy areas of focus
  • Identify new drug targets and therapeutic classes in the Uni-Bio Science Group Ltd.'s R&D portfolio and develop key strategic initiatives to reinforce pipeline in those areas
  • Exploit in-licensing opportunities by identifying windows of opportunity to fill portfolio gaps
  • Develop strategic initiatives by understanding the focus areas of Uni-Bio Science Group Ltd. and exploit collaboration and partnership opportunities
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Plan mergers and acquisitions effectively by identifying the most promising pipeline of Uni-Bio Science Group Ltd.
  • Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope
  • Explore the dormant and discontinued projects of Uni-Bio Science Group Ltd. and identify potential opportunities in those areas
  • Avoid Intellectual Property Rights related issues

Table of Contents

  • Table of Contents
    • List of Tables
    • List of Figures
  • Uni-Bio Science Group Ltd. Snapshot
    • Uni-Bio Science Group Ltd. Overview
    • Key Information
    • Key Facts
  • Uni-Bio Science Group Ltd. - Research and Development Overview
    • Key Therapeutic Areas
  • Uni-Bio Science Group Ltd. - Pipeline Review
    • Pipeline Products by Stage of Development
    • Pipeline Products - Monotherapy
  • Uni-Bio Science Group Ltd. - Pipeline Products Glance
    • Uni-Bio Science Group Ltd. - Late Stage Pipeline Products
      • Pre-Registration Products/Combination Treatment Modalities
      • Phase III Products/Combination Treatment Modalities
    • Uni-Bio Science Group Ltd. - Clinical Stage Pipeline Products
      • Phase I Products/Combination Treatment Modalities
    • Uni-Bio Science Group Ltd. - Early Stage Pipeline Products
      • Preclinical Products/Combination Treatment Modalities
  • Uni-Bio Science Group Ltd. - Drug Profiles
    • teriparatide
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • Uni-E4
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • rhEPO-Fc
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • Extendin-Fc
      • Product Description
      • Mechanism of Action
      • R&D Progress
  • Uni-Bio Science Group Ltd. - Pipeline Analysis
  • Uni-Bio Science Group Ltd. - Pipeline Products by Target
  • Uni-Bio Science Group Ltd. - Pipeline Products by Route of Administration
  • Uni-Bio Science Group Ltd. - Pipeline Products by Molecule Type
  • Uni-Bio Science Group Ltd. - Pipeline Products by Mechanism of Action
  • Uni-Bio Science Group Ltd. - Discontinued Pipeline Products
    • Discontinued Pipeline Product Profiles
      • UNI-rhIL11
  • Uni-Bio Science Group Ltd. - Locations And Subsidiaries
    • Head Office
  • Appendix
    • Methodology
    • Coverage
    • Secondary Research
    • Primary Research
    • Expert Panel Validation
    • Contact Us
    • Disclaimer

List of Tables

  • Uni-Bio Science Group Ltd., Key Information
  • Uni-Bio Science Group Ltd., Key Facts
  • Uni-Bio Science Group Ltd. - Pipeline by Indication, 2015
  • Uni-Bio Science Group Ltd. - Pipeline by Stage of Development, 2015
  • Uni-Bio Science Group Ltd. - Monotherapy Products in Pipeline, 2015
  • Uni-Bio Science Group Ltd. - Pre-Registration, 2015
  • Uni-Bio Science Group Ltd. - Phase III, 2015
  • Uni-Bio Science Group Ltd. - Phase I, 2015
  • Uni-Bio Science Group Ltd. - Preclinical, 2015
  • Uni-Bio Science Group Ltd. - Pipeline by Target, 2015
  • Uni-Bio Science Group Ltd. - Pipeline by Route of Administration, 2015
  • Uni-Bio Science Group Ltd. - Pipeline by Molecule Type, 2015
  • Uni-Bio Science Group Ltd. - Pipeline Products by Mechanism of Action, 2015
  • Uni-Bio Science Group Ltd. - Discontinued Pipeline Products, 2015

List of Figures

  • Uni-Bio Science Group Ltd. - Pipeline by Top 10 Indication, 2015
  • Uni-Bio Science Group Ltd. - Pipeline by Stage of Development, 2015
  • Uni-Bio Science Group Ltd. - Monotherapy Products in Pipeline, 2015
  • Uni-Bio Science Group Ltd. - Pipeline by Top 10 Target, 2015
  • Uni-Bio Science Group Ltd. - Pipeline by Top 10 Route of Administration, 2015
  • Uni-Bio Science Group Ltd. - Pipeline by Top 10 Molecule Type, 2015
  • Uni-Bio Science Group Ltd. - Pipeline Products by Top 10 Mechanism of Action, 2015
Back to Top